Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Heart Test Laboratories, Inc. - Warrant (NQ: HSCSW )

0.0600 UNCHANGED
Streaming Delayed Price Updated: 3:59 PM EDT, Mar 20, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.0600
Bid (Size) 0.0766 (1)
Ask (Size) 0.2350 (5)
Prev. Close 0.0600
Today's Range 0.0600 - 0.0600
52wk Range 0.0600 - 1.750
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2023 Financial Results
From Heart Test Laboratories, Inc.
Via Globe NewsWire
HeartSciences CEO Invited as Featured Guest on The Big Biz Show, February 7 at 11:45 a.m. Pacific Time
From Heart Test Laboratories, Inc.
Via Globe NewsWire

Performance

YTD
-76.10%
-76.10%
1 Month
-72.48%
-72.48%
3 Month
-66.39%
-66.39%
6 Month
-79.31%
-79.31%
1 Year
-82.90%
-82.90%

More News

Read More
HeartSciences Granted Key Israeli International Patent for its MyoVista® Wavelet Technology Utilizing Artificial Intelligence (AI) for Early Detection of Heart Disease
From Heart Test Laboratories, Inc.
Via Globe NewsWire
HeartSciences Announces Further Internationalization of its Patent Portfolio
From Heart Test Laboratories, Inc.
Via Globe NewsWire
Correction: HeartSciences CEO to Participate in the Healthcare IT Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest on January 25th
From Heart Test Laboratories, Inc.
Via Globe NewsWire
HeartSciences CEO to Participate in the Healthcare IT Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest on January 25th
From Heart Test Laboratories, Inc.
Via Globe NewsWire
HeartSciences Appoints David R. Wells to its Board of Directors, an Experienced Capital Markets and Finance Executive
From Heart Test Laboratories, Inc.
Via Globe NewsWire
HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2023 Financial Results
From Heart Test Laboratories, Inc.
Via Globe NewsWire
HeartSciences and Rutgers University Announce Multi-Year Collaboration to Develop AI-based ECG Algorithms
From Heart Test Laboratories, Inc.
Via Globe NewsWire
HeartSciences to Present at the 2022 RHK Disruptive Growth Conference on December 5, 2022
From Heart Test Laboratories, Inc.
Via Globe NewsWire
HeartSciences to Participate at the Benchmark Discovery One-on-One Investor Conference on December 1, 2022
From Heart Test Laboratories, Inc.
Via Globe NewsWire
HeartSciences’ MyoVista® Technology Used to Develop AI-ECG Algorithm to Identify Patients at High-Risk of Major Adverse Cardiovascular Events
From Heart Test Laboratories, Inc.
Via Globe NewsWire
HeartSciences Granted European Patent for Proprietary Electrode and Cable Connections for Use with its AI-Based MyoVista® ECG
From Heart Test Laboratories, Inc.
Via Globe NewsWire
HeartSciences Named as a Top 10 MedTech Startup 2022 by MedTech Outlook Magazine
From Heart Test Laboratories, Inc.
Via Globe NewsWire
HeartSciences to Present at MicroCap Rodeo's Windy City Roundup Conference on October 12th
Via ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.